World's Best Scientists 2026 revealed!
Journal of Thoracic Oncology
H-index 87

Journal of Thoracic Oncology

Ranking & Metrics

Discipline name Position Best Scientists Publications D-Index
Medicine 60 768 2160 86

Additional Metrics

Number of Best Scientists*: 1540
Documents by Best Scientists*: 2845
Top 100 Ranked Scientists*: 45
SCIMAGO H-index: 190
SCIMAGO SJR: 7.948
Impact Factor: 20.8

Overview

Top Research Topics at Journal of Thoracic Oncology?

Internal medicine, Oncology, Lung cancer, Cancer research and Non small cell are among the topics commonly tackled in Journal of Thoracic Oncology. The featured Internal medicine research zeroes in on concepts in Chemotherapy, Lung, Adenocarcinoma and non-small cell lung cancer (NSCLC) but also tackles themes under In patient. The studies in Oncology featured incorporate elements of Phases of clinical research, Survival rate, Stage (cooking), Radiation therapy and Immunotherapy.

Surgery, Cancer, Carcinoma and Radiology are some topics wherein Lung cancer research discussed in it have an impact. The journal focuses on Cancer research research which is adjacent to topics in Mutant.

  • Internal medicine (44.96%)
  • Oncology (40.68%)
  • Lung cancer (37.16%)

What are the most cited papers published in the journal?

  • International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society International Multidisciplinary Classification of Lung Adenocarcinoma (3202 citations)
  • The IASLC Lung Cancer Staging Project: proposals for the revision of the TNM stage groupings in the forthcoming (seventh) edition of the TNM Classification of malignant tumours. (3043 citations)
  • The 2015 World Health Organization Classification of Lung Tumors: Impact of Genetic, Clinical and Radiologic Advances Since the 2004 Classification (1868 citations)

Research areas of the most cited articles at Journal of Thoracic Oncology:

The most cited papers are organized to reinforce research efforts on Lung cancer, Internal medicine, Oncology, Carcinoma and Survival rate. Lung cancer research discussed in the most cited publications aims to provide more information in the subject of Pathology. In addition to Oncology research, the journal publications aim to explore topics under KRAS, Metastasis and Phases of clinical research.

Papers citation over time

A key indicator for each journal is its effectiveness in reaching other researchers with the papers published at that venue.

The chart below presents the interquartile range (first quartile 25%, median 50% and third quartile 75%) of the number of citations of articles over time.

The top authors publishing in Journal of Thoracic Oncology (based on the number of publications) are:

  • Benjamin Besse (143 papers) published 32 papers at the last edition, 29 more than at the previous edition,
  • Fred R. Hirsch (140 papers) published 10 papers at the last edition, 4 more than at the previous edition,
  • Enriqueta Felip (134 papers) published 30 papers at the last edition, 24 more than at the previous edition,
  • Yi-Long Wu (133 papers) published 32 papers at the last edition, 28 more than at the previous edition,
  • Luis Paz-Ares (133 papers) published 35 papers at the last edition, 30 more than at the previous edition.

The overall trend for top authors publishing in this journal is outlined below. The chart shows the number of publications at each edition of the journal for top authors.

Only papers with recognized affiliations are considered

The top affiliations publishing in Journal of Thoracic Oncology (based on the number of publications) are:

  • University of Texas MD Anderson Cancer Center (563 papers) published 82 papers at the last edition, 51 more than at the previous edition,
  • Harvard University (559 papers) published 86 papers at the last edition, 58 more than at the previous edition,
  • Memorial Sloan Kettering Cancer Center (517 papers) published 89 papers at the last edition, 58 more than at the previous edition,
  • Mayo Clinic (307 papers) published 35 papers at the last edition, 8 more than at the previous edition,
  • Samsung Medical Center (261 papers) published 42 papers at the last edition, 33 more than at the previous edition.

The overall trend for top affiliations publishing in this journal is outlined below. The chart shows the number of publications at each edition of the journal for top affiliations.

Publication chance based on affiliation

The publication chance index shows the ratio of articles published by the best research institutions in the journal edition to all articles published within that journal. The best research institutions were selected based on the largest number of articles published during all editions of the journal.

The chart below presents the percentage ratio of articles from top institutions (based on their ranking of total papers).Top affiliations were grouped by their rank into the following tiers: top 1-10, top 11-20, top 21-50, and top 51+. Only articles with a recognized affiliation are considered.

During the most recent 2021 edition, 45.90% of publications had an unrecognized affiliation. Out of the publications with recognized affiliations, 24.17% were posted by at least one author from the top 10 institutions publishing in the journal. Another 9.29% included authors affiliated with research institutions from the top 11-20 affiliations. Institutions from the 21-50 range included 16.40% of all publications and 50.15% were from other institutions.

Returning Authors Index

A very common phenomenon observed among researchers publishing scientific articles is the intentional selection of journals they have already attended in the past. In particular, it is worth analyzing the case when the authors participate in the same journal from year to year.

The Returning Authors Index presented below illustrates the ratio of authors who participated in both a given as well as the previous edition of the journal in relation to all participants in a given year.

Returning Institution Index

The graph below shows the Returning Institution Index, illustrating the ratio of institutions that participated in both a given and the previous edition of the conference in relation to all affiliations present in a given year.

The experience to innovation index

Our experience to innovation index was created to show a cross-section of the experience level of authors publishing in a journal. The index includes the authors publishing at the last edition of a journal, grouped by total number of publications throughout their academic career (P) and the total number of citations of these publications ever received (C).

The group intervals were selected empirically to best show the diversity of the authors' experiences, their labels were selected as a convenience, not as judgment. The authors were divided into the following groups:

  • Novice - P < 5 or C < 25 (the number of publications less than 5 or the number of citations less than 25),
  • Competent - P < 10 or C < 100 (the number of publications less than 10 or the number of citations less than 100),
  • Experienced - P < 25 or C < 625 (the number of publications less than 25 or the number of citations less than 625),
  • Master - P < 50 or C < 2500 (the number of publications less than 50 or the number of citations less than 2500),
  • Star - P ≥ 50 and C ≥ 2500 (both the number of publications greater than 50 and the number of citations greater than 2500).

The chart below illustrates experience levels of first authors in cases of publications with multiple authors.

Exploring Linkages to Other Medical Fields

In the broader medical context, these research topics covered by the Journal of Thoracic Oncology often intersect and overlap with other specializations. A notable pathway to consider is the field of nursing, specifically the realm of oncology nursing and, more increasingly, online nursing programs. According to the World Nursing Association, over 30% of registered nurses work in the field of oncology, managing the care of patients who have cancer. Many of these nurses have specialized knowledge, required to administer chemotherapy, imagery studies, and carry out complicated treatments and a multitude of continuous follow-up care protocol.

An increasing number of these nurses are being trained through online programs that allow for flexibility and access to top tier education. One such example is the online nursing programs in Illinois, which are ranked among the best in the country. These programs offer robust modules on oncology and demonstrate interesting cross-connections to the research undertaken in thoracic oncology.

This correlation points towards a potential area of exploration, strengthening the links between academic research and practical nursing education. It provides a pathway for applying research outcomes to the nursing practice, particularly in the field of thoracic oncology, ultimately contributing to advancements in patient care and treatment.

Top Publications

  • The 2021 WHO Classification of Lung Tumors: Impact of advances since 2015.

    Andrew G. Nicholson;Ming S. Tsao;Mary Beth Beasley;Alain C. Borczuk

    (2021)
    826 Citations
  • A Randomized, Placebo-Controlled Trial of Pembrolizumab Plus Chemotherapy in Patients With Metastatic Squamous NSCLC: Protocol-Specified Final Analysis of KEYNOTE-407

    Luis Paz-Ares;David Vicente;Ali Tafreshi;Andrew Robinson

    (2020)
    495 Citations
  • Atezolizumab in Combination With Carboplatin and Nab-Paclitaxel in Advanced Squamous NSCLC (IMpower131): Results From a Randomized Phase III Trial

    Robert Jotte;Federico Cappuzzo;Ihor Vynnychenko;Daniil Stroyakovskiy

    (2020)
    453 Citations
  • Liquid Biopsy for Advanced NSCLC: A Consensus Statement From the International Association for the Study of Lung Cancer

    Christian Rolfo;Philip Mack;Giorgio V. Scagliotti;Charu Aggarwal

    (2021)
    411 Citations
  • Three-Year Overall Survival with Durvalumab after Chemoradiotherapy in Stage III NSCLC-Update from PACIFIC.

    Jhanelle E. Gray;Augusto Villegas;Davey Daniel;David Vicente

    (2020)
    371 Citations
  • SCLC Subtypes Defined by ASCL1, NEUROD1, POU2F3, and YAP1: A Comprehensive Immunohistochemical and Histopathologic Characterization

    Marina K Baine;Min-Shu Hsieh;W. Victoria Lai;Jacklynn V. Egger

    (2020)
    351 Citations
  • Four-Year Survival With Durvalumab After Chemoradiotherapy in Stage III NSCLC-an Update From the PACIFIC Trial.

    Corinne Faivre-Finn;David Vicente;Takayasu Kurata;David Planchard

    (2021)
    351 Citations
  • A Grading System for Invasive Pulmonary Adenocarcinoma: A Proposal From the International Association for the Study of Lung Cancer Pathology Committee.

    Andre L. Moreira;Paolo S.S. Ocampo;Yuhe Xia;Hua Zhong

    (2020)
    343 Citations
  • IMpower150 Final Overall Survival Analyses for Atezolizumab Plus Bevacizumab and Chemotherapy in First-Line Metastatic Nonsquamous NSCLC

    Mark A. Socinski;Makoto Nishio;Robert M. Jotte;Federico Cappuzzo

    (2021)
    320 Citations
  • Atezolizumab Plus Chemotherapy for First-Line Treatment of Nonsquamous NSCLC: Results From the Randomized Phase 3 IMpower132 Trial.

    Makoto Nishio;Fabrice Barlesi;Howard West;Simon Ball

    (2021)
    320 Citations

Related Online Degrees & Career Pathways

For those interested in Medicine in the USA, exploring related online degrees can provide valuable foundations and alternative career options. An online bachelor's degree in biology offers essential scientific knowledge critical for medical school and biomedical research.

If you’re leaning toward hands-on patient care but not immediately pursuing an MD, an asn online program prepares students for nursing roles, often serving as a stepping stone to advanced nursing degrees and healthcare careers.

Nutrition plays a crucial role in healthcare and wellness. Pursuing an online nutrition degree can open doors to careers in dietetics, public health, and health education, complementing traditional medical knowledge.

For those interested in the administrative side of healthcare, a master's from cahme accreditation mha programs provides leadership skills tailored to healthcare management. This path is ideal for professionals looking to influence healthcare delivery and policy.

Best Scientists Contributing to This Journal

Recently Published Articles